Skip to main content
. 2017 May 24;6(7):1627–1638. doi: 10.1002/cam4.1092

Table 1.

OS and DFS rates for all patients in the first and second discovery cohorts

# patients OS DFS
Dead Survive # Probes Relapse Nonrelapse # Probes
First cohort 11 70 9980 19 62 9973
Second cohort 8 8 15,589 5 11 15,102
Combined cohort 19 78 10,337 24 73 10,611